ASCENIV utilization in a primary immunodeficiency patient with recurrent viral infections.
Immunol Med
; 46(1): 58-60, 2023 Mar.
Article
in English
| MEDLINE | ID: covidwho-2278763
ABSTRACT
Primary immunodeficiency (PI) patients may still experience persistent viral and bacterial respiratory infections with ongoing treatments. We report a challenging case of a PI patient who experienced recurrent viral respiratory infections despite receiving standard immunoglobulin replacement therapy. The patient was subsequently managed with immune globulin intravenous, human-slra (ASCENIV™) that contains elevated antibodies against multiple respiratory pathogens. The patient demonstrated significant clinical improvement with a resolution of persistent and debilitating viral respiratory infections and associated sequela.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Respiratory Tract Infections
/
Bacterial Infections
/
Virus Diseases
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Immunol Med
Year:
2023
Document Type:
Article
Affiliation country:
25785826.2022.2151170
Similar
MEDLINE
...
LILACS
LIS